TGF-β and its coreceptors in cancerogenesis: an overview

Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts

(2011) Wenxia Meng et al.   BMC CANCER

The Role of the TGF-β Coreceptor Endoglin in Cancer

(2011) Eduardo Pérez-Gómez et al.   TheScientificWorldJOURNAL

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status

(2011) Annika J. Bock et al.   TUMOR BIOLOGY

The TGF-β co-receptor endoglin modulates the expression and transforming potential of H-Ras

(2010) Juan F. Santibanez et al.   CARCINOGENESIS

Endoglin suppresses human prostate cancer metastasis

(2010) Minalini Lakshman et al.   CLINICAL & EXPERIMENTAL METASTASIS

Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily

(2010) Sergei Radaev et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma

(2010) E Pardali et al.   ONCOGENE

Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome

(2010) L A Henry et al.   ONCOGENE

Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes

(2010) K.W. Finnson et al.   OSTEOARTHRITIS AND CARTILAGE

Endoglin-Targeted Cancer Therapy

(2010) Ben K. Seon et al.   Current Drug Delivery

TβR-II Discriminates the High- and Low-Affinity TGF-β Isoforms via Two Hydrogen-Bonded Ion Pairs†

(2009) Jason Baardsnes et al.   BIOCHEMISTRY

The emerging role of TGF-β superfamily coreceptors in cancer

(2009) Carmelo Bernabeu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Expression of endoglin (CD105) in cervical cancer

(2009) H J Zijlmans et al.   BRITISH JOURNAL OF CANCER

The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling

(2009) Jason D. Lee et al.   CARCINOGENESIS

Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours

(2009) E. Fonsatti et al.   CARDIOVASCULAR RESEARCH

Stage-related plasma values of transforming growth factor-beta1 are steroid receptors dependent

(2009) Nataša Todorović-Raković et al.   CLINICAL AND EXPERIMENTAL MEDICINE

TGF-ß signaling, tumor microenvironment and tumor progression: the butterfly effect

(2009) Amit Joshi   Frontiers in Bioscience-Landmark

The type III TGF-  receptor regulates epithelial and cancer cell migration through  -arrestin2-mediated activation of Cdc42

(2009) K. Mythreye et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Knockdown of the Transforming Growth Factor-  Type III Receptor Impairs Motility and Invasion of Metastatic Cancer Cells

(2008) T. L. Criswell et al.   CANCER RESEARCH

Expression of the type III TGF-β receptor is negatively regulated by TGF-β

(2008) Nadine Hempel et al.   CARCINOGENESIS

TβRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity

(2008) Elizabeth C. Finger et al.   CARCINOGENESIS

Roles of TGFβ in metastasis

(2008) David Padua et al.   CELL RESEARCH

Silencing of Transforming Growth Factor- 1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo

(2008) L. D. Moore et al.   CLINICAL CANCER RESEARCH

Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype

(2008) D Oxmann et al.   ONCOGENE